Boston Company Tests Cannabis for Potency, Terpenes and Residual Solvents with One Device

908 Devices Launches 3-in-1 GC-HPMS Analyzer to Increase Quality and Efficiency Throughout Cannabis Production and Testing Industries

Cannabis lab technicians, growers and producers benefit from rapid identification and quantitation of analytes in cannabis strains

June 27, 2017

BOSTON–(BUSINESS WIRE)–908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced the introduction of the G908 3-in-1 Cannabis Analyzer. This innovative device combines the Company’s patented and award-winning high-pressure mass spectrometry™ (HPMS) technology with the separating power of ballistic gas chromatography (GC), enabling customers throughout the cannabis testing industry to perform three state required tests on one device: total potency, terpenes and residual solvents. As a result, users at all skill levels can accelerate the analysis process for a wide range of compounds associated with cannabis production, reducing analysis time by more than 80 percent to save both time and money.

As we march towards our goal of making gold-standard analysis more accessible, we saw a real opportunity to bring our powerful GC-HPMS technology combination to the cannabis testing industry. With G908, all those involved in the production, testing, and distribution of cannabis products will benefit from an easy-to-use, affordable device that can keep pace with continuous changes in regulations and testing needs.

Dr. Kevin J. Knopp, President and CEO, 908 Devices

With state regulations requiring products to pass safety, purity and quality tests before distribution, those involved in the growing, manufacturing and testing of cannabis products need a fast, rigorous analysis solution to ensure compliance. Unlike legacy instruments found in today’s laboratories, this 3-in-1 analyzer is easy-to-use and offers professional-grade analysis on cannabis strains at the push of a button. Designed for durability and transportability, G908 can rapidly perform testing in the laboratory and at remote field-based settings. What’s more, G908 is a cost-effective device. Not only does the device cost less than legacy lab instruments, it was designed with field serviceable components and very few required consumables, so maintenance and upkeep costs are significantly reduced. This eases the financial burden placed on growers, producers and labs looking to streamline acquisition of new instruments.

In the lab, G908’s small footprint and compound selectivity eliminates the need for multiple, complex analytical instruments. The combination of HPMS and GC provides exceptionally fast compositional analysis, enabling technicians to scale up operations and successfully manage the hundreds of samples they need to test each day. Notably, G908 can perform analysis on residual solvents 5x faster than legacy instruments in the lab. For growers and producers, on-site testing capabilities will significantly increase their chances of passing state-sanctioned testing. The ability to test products on-site throughout the cultivation, extraction and manufacturing processes provides growers and producers with the ability to determine optimum harvest conditions, and identify potential product quality problems early to take corrective action. In turn, this reduces the risk of having batches quarantined or destroyed.

The lack of standardization throughout the industry has proved to be challenging as we work towards compliance while also trying to remain profitable. As this industry matures, and the number of samples we receive for testing continues to grow, G908’s rapid analysis will be a game-changer for our team.

Dr. Christopher J. Hudalla, Founder and Chief Scientific Officer, ProVerde Laboratories

This disruptive technique will enable us to keep pace with the number of samples we receive without having to compromise on accuracy. By leveraging G908, we can continue our mission of revolutionizing the state’s medical marijuana industry while also serving as a resource for doctors and researchers examining the medicinal uses of marijuana.

“Users throughout the industry – regardless of skill level – will benefit from the fast-compositional analysis provided by this new cannabis analyzer,” said Dr. Graham Shelver, Commercial Leader, Applied Markets, 908 Devices.“ From accurate terpene profiling with component mass confirmation and calculation of solvent residue concentrations in complex matrices to neutral cannabinoid total potency results, G908 rapidly identifies and quantifies a wide selection of compounds present in cannabis strains. As a result, customers in both testing labs and at production facilities will be well equipped for detecting and identifying molecules at the concentration limits this industry requires.”

To learn more about 908 Devices’ G908 3-in-1 Cannabis Analyzer, please visit:, email or meet the team by visiting us at the Cannabis Science Conference, booth #139 and CannaGrow Expo, booth #215. For those looking to make a purchase, 908 Devices most recently signed a co-exclusive agreement with Quantum Analytics. Under the terms of this agreement, U.S. customers across the full range of applied markets will also be able to purchase the G908 analyzer directly from Quantum Analytics with financing options for cannabis customers also available.

For company news and updates, follow us on Twitter at @908Devices and on LinkedIn at

About 908 Devices

908 Devices is democratizing chemical analysis by way of mass spectrometry, offering point-of-need chemical and biomolecule analysis devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices. These purpose-built and user-centric devices serve a range of industries, including safety & security, life sciences, cannabis, hydrocarbon processing, and other applied markets. 908 Devices is headquartered in the heart of Boston where they research, design and manufacture innovative products based on high-pressure mass spectrometry™ (HPMS) and microfluidic separation technology. For more information, visit

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter